This list is an analysis based on recent market events. It's not an investment recommendation.
About
Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.
The current price of MLCT is $0.2 USD — it has increased by +2.63% in the past 24 hours. Watch Vitality Biopharma stock price performance more closely on the chart.
What is Vitality Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vitality Biopharma stocks are traded under the ticker MLCT.
What were Vitality Biopharma earnings last quarter?▼
MLCT earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vitality Biopharma revenue for the last year?▼
Vitality Biopharma revenue for the last year amounts to 4.83M USD.
What is Vitality Biopharma net income for the last year?▼
MLCT net income for the last year is -1.07M USD.
How many employees does Vitality Biopharma have?▼
As of April 01, 2026, the company has 3 employees.
In which sector is Vitality Biopharma located?▼
Vitality Biopharma operates in the Manufacturing sector.
When did Vitality Biopharma complete a stock split?▼
Vitality Biopharma has not had any recent stock splits.